Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cholesterolemia and pathology: update]

J L Schlienger1, B Goichot, A Pradignac

  • 1Service de médecine interne, CHRU, hôpital de Hautepierre, Strasbourg, France.

La Revue De Medecine Interne
|October 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

International journal of surgery (London, England)·2024
Same author

Controversy: Pros and cons screening of corticotropic deficiency after exogenous glucocorticoid therapy.

Annales d'endocrinologie·2018
Same author

Subclinical haemorrhage in non-functional adenomas.

Neuro-Chirurgie·2018
Same author

An unusual pituitary stalk lesion: What is the place of surgery?

Neuro-Chirurgie·2017
Same author

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

European journal of endocrinology·2015
Same author

Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.

Clinical endocrinology·2015
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

The link between high cholesterol and heart disease is clear. However, low cholesterol

Area of Science:

  • Cardiovascular Science
  • Metabolic Disorders
  • Epidemiology

Context:

  • The established role of hypercholesterolemia in ischemic heart disease.
  • The controversial effects of hypocholesterolemia on cancer mortality and violent death.
  • The complexity of cholesterol's relationship with various diseases.

Purpose:

  • To analyze the nuanced relationship between plasma cholesterol levels and disease outcomes.
  • To evaluate the controversial aspects of hypocholesterolemia.
  • To provide a balanced perspective on cholesterol management.

Summary:

  • While high cholesterol (hypercholesterolemia) is definitively linked to ischemic heart disease, the negative impacts of low cholesterol (hypocholesterolemia) on cancer mortality and violent death remain debated.

Related Experiment Videos

  • The extent of cholesterol reduction, rather than hypocholesterolemia itself, appears more significant prognostically.
  • Hypocholesterolemia is not considered a direct causal factor for these adverse outcomes.

    • Impact:

    • Highlights the complexity of cholesterol's role in disease beyond ischemic heart disease.
    • Suggests a need for careful consideration of cholesterol reduction extent in patient prognosis.
    • Supports a prudent approach to managing hypercholesterolemia without drastic changes to current guidelines.